$DHR

3 theses

bullish 33%neutral 0%bearish 67%

Avg return (3d)

+4.4%

Win rate (3d)

100% (1 resolved)

1d 3d 1w 1m 3m 6m 1y

Past performance does not predict future results. Informational only, not investment advice.

Recent theses

Prices as of Oct 29, 4:45 PM ET

$DHRSEC Form 4bearish

Bouda Christopher · VP, Chief Accounting Officer at DANAHER CORP /DE/ · 4h agono track record yet

Sold 7,598 @ $234.56 avg · $1,782,157 · 2026-10-28

Form 4: Bouda Christopher sold DHR

Bouda Christopher (VP, Chief Accounting Officer at DANAHER CORP /DE/) reported an open-market sale of 7,598 shares of DHR at an average $234.56, roughly $1,782,157, in a Form 4 filed 2026-10-29.

At post $236.98Now $236.980.0% since postedas of Oct 29, 4:45 PM ET

View filing on SEC.gov →

$DHRSEC Form 4bearish

McGrew Matthew · Executive Vice President at DANAHER CORP /DE/ · 4h agono track record yet

Sold 29,754 @ $235.74 avg · $7,014,244 · 2026-10-28

Form 4: McGrew Matthew sold DHR

McGrew Matthew (Executive Vice President at DANAHER CORP /DE/) reported an open-market sale of 29,754 shares of DHR at an average $235.74, roughly $7,014,244, in a Form 4 filed 2026-10-29.

At post $236.98Now $236.980.0% since postedas of Oct 29, 4:45 PM ET

View filing on SEC.gov →

$DHRr/ValueInvestingStock Analysisbullish

u/raytoei · 166d ago25 prior · 60% at 3mo

10 Quality Stocks That Hit New Lows This Week—and Look Like Bargains - Barron’s

Danaher declined 28% this year despite strong end markets in biotech diagnostics and equipment, with weakness driven by just 1% core sales growth in Q1. The stock trades at 20x 2026 earnings with 8% expected earnings growth in 2026–2027 and a long-term double-digit growth target.

At post $163.23Now $236.98+45.2% since postedas of Oct 29, 4:45 PM ET

1d—

3d+4.4%

1w+5.0%

1m+10.7%

3m+23.8%

6m—

1y—

original post →

End of results.